3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Rectal Neoplasms
2
Prostatic Neoplasms
2
Lung Neoplasms
2
Leukemia
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms, Male
2
Adenocarcinoma Of Esophagus
2
Triple Negative Breast Neoplasms
1
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Multiple Myeloma
1
Liposarcoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Kidney Neoplasms
1
Gliosarcoma
1
Glioma, Subependymal
1
Glioma
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Interventions
Rituximab
49
fludarabine phosphate
32
Cyclophosphamide
30
Whole-Body Irradiation
26
Peripheral Blood Stem Cell Transplantation
25
Mycophenolic Acid
24
Tacrolimus
19
Cyclosporine
16
Dexamethasone
13
Busulfan
13
ibrutinib
12
Sirolimus
12
Bortezomib
11
Antilymphocyte Serum
11
Melphalan
10
Etoposide
10
Calcium Dobesilate
10
Methotrexate
8
Lenalidomide
8
Cyclosporins
8
idelalisib
7
Everolimus
6
Indium
5
Filgrastim
5
thymoglobulin
4
ibritumomab tiuxetan
4
carfilzomib
4
Vincristine
4
Prednisone
4
In Situ Hybridization, Fluorescence
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Waldenstrom Macroglobulinemia
×
Reverse Transcriptase Polymerase Chain Reaction
×
Clear all
No trials found.